HIV/AIDS
Studies from the United States and People's Republic of China add new findings to HIV/AIDS body of knowledge
Published in AIDS Weekly, May 15th, 2006
Study 1: A T-cell-based reporter system screens antiretroviral drugs.
"The rapid increase of viral strains that are resistant to the currently available antiretroviral drugs is a threat to the success of current human immunodeficiency virus type 1 (HIV-1) treatment and emphasizes the importance of developing novel anti-HIV-1 compounds.
"To improve the current abilities to screen for novel HIV-1 inhibitors, here we introduce a T-cell-based reporter cell line (JLTRG-RS) that expresses both HIV-1 coreceptors, CXCR4 and CCRS, and provides...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2006-05-15)
More Articles from AIDS Weekly
- HIV-1/HTLV-II Coinfection
HIV-1/HTLV-II coinfection associated with greater immunodeficiency - HIV/AIDS HAART
Permanent HIV suppression may be achieved with immunomodulants in association with HAART - HIV/AIDS Pathogenesis
HIV-1 pathogenesis predictions differ between three mathematical models - HIV/AIDS Pathogenesis
HIV-1 superinfected cells show increased mortality - HIV/AIDS Prognostic Indicator
Higher HIV viral load associated with mannose-binding lectin gene polymorphism - Antimicrobials
Alligator leukocyte extracts have broad spectrum antimicrobial activity - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
